·
4 Min Read

How the FDA’s approaching COVID-19 vaccines for kids under 5

The FDA’s Dr. Peter Marks discusses timeline, knows parents are desperate for a vaccine. He also covers second boosters and the J&J vaccine.

Infectious Diseases

Membership Moves Medicine™

  • Thousands of free CME opportunities to fulfill state requirements
  • A powerful voice fighting for you during uncertain times
  • Research, resources, events and more from the largest physician organization
May 9, 2022 ·
40 Min Read

COVID-19 fourth dose boosters and vaccine update with Peter Marks, MD

In the latest from the COVID-19 webinar series, Peter Marks, MD, PhD, addresses a host of topics related to the fourth dose booster vaccine and updates on pediatric vaccine safety data. Watch the recording.

series
Events
COVID-19: What Physicians Need to Know Webinar Series
Peter Marks, MD, PhD
·
4 Min Read

FDA’s Dr. Marks among 7 honored by AMA for work amid pandemic

Dr. Marks helped assure safety, efficacy of COVID-19 vaccines and kept physicians up to date. Learn about the other AMA award honorees.

Awards
·
2 Min Read

AMA presents Government Service Award to FDA official

The AMA presented Peter Marks, M.D., Ph.D., director of the FDA with the AMA Award for Outstanding Government Service.

Press Releases
Apr 13, 2021 ·
42 Min Read

Peter Marks, MD, PhD, discusses Johnson & Johnson COVID-19 vaccine pause

On April 13, 2021, the AMA hosted the seventh webinar in the "COVID-19: What physicians need to know" series. Learn more.

series
Events
COVID-19: What Physicians Need to Know Webinar Series
Jan 29, 2021 ·
42 Min Read

FDA Director Peter Marks, MD, PhD, discusses COVID-19 vaccine safety & delivery

On Jan. 29, 2021, the AMA hosted the fifth webinar in the "COVID-19: What physicians need to know" series, focusing on COVID-19 vaccine delivery. Learn more.

series
Events
COVID-19: What Physicians Need to Know Webinar Series
Dec 3, 2020 ·
41 Min Read

COVID-19 vaccine update from FDA Director Peter Marks, MD, PhD

In this update, learn how the Emergency Use Authorization process (EUA) is being used to safely deliver accelerated approval for a COVID-19 vaccine.

series
Events
COVID-19: What Physicians Need to Know Webinar Series
Person receiving a vaccine.
·
5 Min Read

How the FDA plans to build physician trust for COVID-19 vaccine

A top FDA scientist answers doctors’ questions and details how the agency's SARS-CoV-2 vaccine-review process is driven by transparency and evidence.

Infectious Diseases